Meningitis Vaccine Market Scope And Analysis

  • Report Code : TIPRE00012159
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Meningitis Vaccine Market Growth and Scope - 2031

Buy Now

Meningitis Vaccine Market Report Meningitis Vaccine Market Size and Share Meningitis Vaccine Market Scope and Analysis

Meningitis Vaccine Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 6.1%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Vaccine Type
  • Haemophilus influenza type b vaccine
  • pneumococcal conjugate vaccine
  • pneumococcal polysaccharide vaccine
  • meningococcal vaccine
  • others
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Astellas Pharma Inc
  • Bavarian Nordic
  • CSL Limited
  • Emergent BioSolutions Inc
  • GlaxoSmithKline plc
  • Johnson Johnson
  • MedImmune LLC
  • Merck Co Inc
  • Mitsubishi Tanabe Pharma Corporation
    		•